These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24622463)

  • 1. Determining the combined effect on invasiveness and carcinogenesis process: matrix metalloproteinas/tissue inhibitor of metalloproteinase ratio.
    Yalcinkaya E; Celik M; Gormel S
    Chin Med J (Engl); 2014; 127(6):1196. PubMed ID: 24622463
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of tissue inhibitor of matrix metalloproteinase-1 correlate with diagnosis and prognosis of glioma patients.
    Lin Y; Wang JF; Gao GZ; Zhang GZ; Wang FL; Wang YJ
    Chin Med J (Engl); 2013 Nov; 126(22):4295-300. PubMed ID: 24238516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer.
    Laitinen A; Hagström J; Mustonen H; Kokkola A; Tervahartiala T; Sorsa T; Böckelman C; Haglund C
    Tumour Biol; 2018 Sep; 40(9):1010428318799266. PubMed ID: 30192205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure.
    Gerlach RF; Tanus-Santos JE
    Am Heart J; 2006 Jul; 152(1):e9. PubMed ID: 16824824
    [No Abstract]   [Full Text] [Related]  

  • 5. By mistakes we learn: determination of matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 in serum yields doubtful results.
    Emingil G; Afacan B; Tervahartiala T; Töz H; Atilla G; Sorsa T
    J Clin Periodontol; 2008 Dec; 35(12):1087-8. PubMed ID: 18983634
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease.
    Korematsu S; Ohta Y; Tamai N; Takeguchi M; Goto C; Miyahara H; Kawano T; Izumi T
    Pediatr Infect Dis J; 2012 Sep; 31(9):973-4. PubMed ID: 22895216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
    Berend KR; Toth AP; Harrelson JM; Layfield LJ; Hey LA; Scully SP
    J Bone Joint Surg Am; 1998 Jan; 80(1):11-7. PubMed ID: 9469303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort.
    Kormi I; Nieminen MT; Havulinna AS; Zeller T; Blankenberg S; Tervahartiala T; Sorsa T; Salomaa V; Pussinen PJ
    Eur J Prev Cardiol; 2017 Jul; 24(11):1136-1144. PubMed ID: 28429955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis.
    Gerlach RF; Tanus-Santos JE
    Clin Neurol Neurosurg; 2006 Sep; 108(6):617-8; author reply 618. PubMed ID: 16413675
    [No Abstract]   [Full Text] [Related]  

  • 10. Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome.
    Bertsch T; Sueselbeck T; Wolpert C; Hoffmann U; Kaden JJ; Haase KK; Borggrefe M; Brueckmann M
    Clin Chem Lab Med; 2005; 43(6):660-3. PubMed ID: 16006264
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms.
    Monaco M; Stassano P; Di Tommaso L; Iannelli G
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):925-31. PubMed ID: 17903509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in plasma/serum and urine of women during term and threatened preterm labor: a clinical approach.
    Makrakis E; Grigoriou O; Kouskouni E; Vitoratos N; Salamalekis E; Chatzoudi E; Creatsas G
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):170-6. PubMed ID: 14694972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misuse of serum matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 as a biomarker in multiple sclerosis.
    Gerlach RF; Tanus-Santos JE
    Mult Scler; 2006 Feb; 12(1):120. PubMed ID: 16459731
    [No Abstract]   [Full Text] [Related]  

  • 14. Seasonal variation and stability of matrix metalloproteinase-9 activity and tissue inhibitor of matrix metalloproteinase-1 with storage at -80°C.
    Tarr GP; Williams MJ; Phillips LV; van Rij AM; Jones GT
    Clin Biochem; 2011 Nov; 44(16):1346-8. PubMed ID: 21939646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. By mistakes we learn: determination of matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 in serum yields doubtful results.
    Jung K; Lein M
    J Clin Periodontol; 2009 Jan; 36(1):34-5; author reply 36-8. PubMed ID: 19018883
    [No Abstract]   [Full Text] [Related]  

  • 16. Validating sampling methods for measurement of circulating matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1.
    Zhang RY; Cui W; Zhao KJ; Tang YQ; Li L
    Pancreas; 2010 Aug; 39(6):937; author reply 937-8. PubMed ID: 20664481
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlations between papillary thyroid cancer and peripheral blood levels of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and tissue inhibitor of metalloproteinase-2.
    Zhou SF; Hu SY; Ma L; Miao L; Mao WZ
    Chin Med J (Engl); 2013; 126(10):1925-9. PubMed ID: 23673111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in serum do not reflect the analytes circulating in blood.
    Jung K
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):e15-6; author reply e17. PubMed ID: 18048765
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma].
    Yoshikawa T; Suzuki K; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y; Tsuburaya A
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1461-4. PubMed ID: 9703854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases-2, -9 and tissue inhibitor of metallo-proteinase-1 in lung cancer invasion and metastasis.
    Ming SH; Sun TY; Xiao W; Xu XM
    Chin Med J (Engl); 2005 Jan; 118(1):69-72. PubMed ID: 15642229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.